Leuprolide
Drug that affects hypothalamic hormones
Used as antineoplastic agent for treatment of spefic cancers
Treatment of endometriosis and precocious putty that results from hypothalamic activity
Leuprolide Actions
GnRH agonist that occupies pituitary GnRH receptors and desensitizes them; causes an initial increase and then profound decrease in LH and FSH levels.
Leuprolide Adverse Effects
Dizziness, headache, pain, peripheral edema, myocardial infarction, nausea, vomiting, anorexia, constipation, urinary frequency, hematuria, hot flashes, increased sweating, malaise, fatigue, emotional lability, injection site pain, convulsions, testicular atrophy, decreased bone density, hyperglycemia.
Desmopressin
Treatment of neurogenic diabetes insipidus, von Willebrand disease, hemophilia; treatment of nocturia due to nocturnal polyuria in adults.
Desmopressin Actions
Has pressor and antidiuretic effects; increases levels of clotting factor VIII.
Desmopressin Adverse Effects
eadache, dry mouth, facial flushing, nausea, fluid retention, slight increase in blood pressure, local reaction at injection site, water intoxication at high doses
ADH
Vasopressin
Released from posterior pituitary in respsone to increased in plasma osmolarity or decrease in blood volume.
Antidiuretic activity in the kidneys
Vaspopressin blocker cause a loss of water through the urine and increases serum Na levels as water decreases
Octreotide
Growth hormone antagonists
Treatment/maintenacne of acromegaly in adults who are not candidates for or cannot tolerate other therapy
Treatment for severe diarrhea/flusing with metastatic carcinoid tumors
Hypothalamic Hormones
Factors to either stimulate or inhibit the release of hormones from the anterior pituitary.
Factors that stimulate the release of hormones are growth hormone–releasing hormone (GHRH), thyrotropin-releasing hormone (TRH), gonadotropin-releasing hormone (GnRH), corticotropin-releasing hormone (CRH), and prolactin-releasing hormone (PRH).
Factors that inhibit the release of hormones are somatostatin (growth hormone–inhibiting factor) and prolactin-inhibiting factor (PIF).